Search results
Results from the WOW.Com Content Network
Once fully operational, Kodak Pharmaceuticals would have the capacity at Eastman Business Park to produce up to 25 percent of active pharmaceutical ingredients used in non-biologic, non-antibacterial, generic pharmaceuticals while supporting 360 direct jobs and an additional 1,200 indirectly.
July 28, 2020: Kodak won a government loan to transform into a pharmaceutical ingredients producer. White House trade adviser Peter Navarro said the company’s expertise in fine chemicals was ...
Eastman Kodak, famous for its cameras, will now enter the drug manufacturing industry. With a $765 million federal loan under the Defense Production Act, the company will scale production of ...
Last month, the U.S. government announced a letter of interest to provide Kodak with a $765 million loan to manufacture pharmaceutical ingredients. The deal is now on hold as the SEC...
A massive deal was in the works with a $765 million dollar federal loan for Kodak to launch a new venture by making generic drug ingredients.
Rochester, New York-based Kodak will receive a $765 million dollar loan under the Defense Production Act to manufacture key starting materials and active pharmaceutical ingredients.
Eastman Kodak Company officials, along with Washington D.C. leaders, announced an agreement for a $765 million federal loan to support the launch of Kodak Pharmaceuticals — a new arm of the company that poses to transform the business into an industry leader in prescription drug manufacturing.